MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars) _ Neurodegenerative; Neuromuscular, Neuropsychiatric
Entrada Therapeutics, Inc. (NASDAQ:TRDA)*
Organization & Developments: Entrada Therapeutics
Parents
Entrada Therapeutics, Inc. (NASDAQ:TRDA)*
Children
2021: Entrada Therapeutics: Advancing A New Class Of Medicines Called EEV
EEVs comprise small cyclic peptides chemically conjugated to any specific active biological therapeutic, and designed to act upon intracellular targets hitherto considered inaccessible and undruggable.
Entrada is built on a platform designed to get biologics across cell membranes to hit intracellular targets.
Entrada is conjugating biologics to cell-penetrating peptides that induce endocytic uptake
Entrada Therapeutics, Inc. (TRDA) is a preclinical stage biotechnology company advancing a new class of medicines called the endosomal escape vehicle (EEV).
Jumps
Finance & Acquisitions: Entrada Therapeutics
Key People: Entrada Therapeutics